Normal view MARC view ISBD view

Endovascular repair of spontaneous or traumatic iliac vein rupture. [electronic resource]

By:

Zieber, Steven R

Contributor(s):

Producer: 20060816Description: 853-6 p. digitalISSN:

1051-0443

Subject(s):

Online resources:

Available from publisher's website

In: Journal of vascular and interventional radiology : JVIR vol. 15

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Case Reports; Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 [Cytokines and their antagonists in the treatment of rheumatoid arthritis].
by Klimiuk, Piotr A
2 [Therapeutic efficacy of peloid plasters in the treatment of osteoarthritis of the peripheral joints and spondylosis].
by Klimiuk, Piotr Adrian
3 [Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis].
by Klimiuk, Piotr Adrian
4 [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
by Klimiuk, Piotr A
5 Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
by Kuryliszyn-Moskal, Anna
6 Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients.
by Ciołkiewicz, Mariusz
7 [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
by Kuryliszyn-Moskal, Anna
8 [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
by Klimiuk, Piotr Adrian
9 Serum chemokines in patients with rheumatoid arthritis treated with etanercept.
by Klimiuk, Piotr Adrian
10 Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
by Klimiuk, Piotr Adrian
11 [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
by Fiedorczyk, Małgorzata
12 The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.
by Klimiuk, Piotr Adrian
13 Successful administration of BI 695501, an adalimumab biosimilar, using an autoinjector (AI): results from a Phase II open-label clinical study (VOLTAIRE
by Cohen, Stanley
14 [Kidneys in rheumatoid arthritis].
by Lewandowski, Bogdan
15 Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers.
by Klimiuk, Piotr Adrian
16 Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
by Kuryliszyn-Moskal, Anna
17 Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.
by Kuryliszyn-Moskal, Anna
18 [The usefulness of capillaroscopy for the evaluation of pulsed magnetic field therapy in patients with primary and secondary Raynaud's phenomenon].
by Kuryliszyn-Moskal, Anna
19 [Defect of glycosylation of immunoglobulin G in rheumatoid arthritis patients].
by Gińdzieńska-Sieśkiewicz, Ewa
20 A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis.
by Kuryliszyn-Moskal, Anna